2018 American Transplant Congress Archives

Ultra Low Dose of IL-2 Produces Long-Term Drug-Free Survival of Cynomolgus Islets Allografts

M. Koulmanda,¹ V. Chipashivili,¹ L. Li,¹ M. Duggan,² T. Strom.¹
Ultrastructural Changes in Lung Allografts: Endothelial Changes Correlate with Donor Specific Antibody & Antibody Mediated Rejection

M. Alexander, A. Bentall, P. Abell Aleff, J. Scott, A. Roden.
Umbilical Cords-Derived Mesenchymal Stem Cells Ameliorates Hepatic Ischemia-Reperfusion Injury via Activating the AMPK-mTOR/ULK1 Signaling Pathway Enhanced Autophagy

J. Zheng,^1,2 J. Cai,^1,2 L. Chen,^1,2 J. Yao,^1,2 K. Zeng,^1,2 H. Li,^1,2 Y. Zhang,^1,2 Y. Yang.^1,2
Unbiased Sequencing of Urine Cell-Free DNA (cfDNA) to Evaluation Urine Virome and Associated Renal Allograft Damage

D. Dadhania,¹ P. Burnham,² J. Lee,¹ C. Snopkowski,¹ C. Li,¹ S. Albakry,¹ H. Yang,¹ T. Muthukumar,¹ I. De Vlaminck,² M. Suthanthiran.¹
Unilateral vs. Bilateral Dual Kidney Transplantation: University of Bologna Experience

M. Del Gaudio,¹ M. Ravaioli,¹ C. Zanfi,¹ V. Bertuzzo,¹ L. Maroni,¹ G. La Manna,² G. Liviano,² A. Siniscalchi,³ A. D'Errico,⁴ A. Pinna.¹
Unique Gene Expression Signatures in Urine Distinguish BK Virus Nephropathy from Acute Rejection in Kidney Transplant Patients with Graft Dysfunction

K. Keslar,¹ P. Gotwald,¹ W. Xu,² A. Zmijewska,³ J. Chen,³ K. Newell,⁴ P. Heeger,⁵ J. Bromberg,⁶ R. Mannon,³ R. Fairchild,¹ The CTOT Consortium.
Unique Recipient Benefits with Paired Kidney Donation

J. Buggs,¹ E. Rogers,² V. Bowers.¹
Unraveling the Neuroimmunological Pathways Surrounding Brain Death: Systematic Study of Clinically Relevant Serum Biomarker Changes during Donor Management from Admission to Procurement

K. Bera, M. LoFaro, H. Huang, S. Maslau, R. Ploeg.
Unsupervised Analysis of the Alloimmune Response in a Novel Model of Vascularized Composite Allotransplantation

J. Harden, A. Sang, X. Qu, C. Esquivel, O. Martinez, S. Krams.
UPMC Living Donor Champion Program

C. Caruso, C. Zell, G. Swaytha, B. Angela, S. Sarah, L. Elaine, P. Susan, W. Travis, H. Abhinav.
Upper Limb and Craniofacial VCA Donors in the US

J. Wainright, C. Wholley, W. Cherikh, J. Rosendale, D. Klassen.
Upper Limb Early Cannulation Arteriovenous Grafts (ecAVG) for Complex Vascular Access – A Healthy Alternative to Central Venous Catheters (CVC)

M. Khurram,¹ I. Mosca,² F. Calder.³
Upper Limb Transplantation in the US: An Early Look at OPTN Data

J. Wainright,¹ L. Levin,² C. Wholley,¹ W. Cherikh,¹ D. Klassen,¹ L. Cendales.³
Upregulated IL-33 in Heart Transplants Modulates Local Myeloid Populations to Protect against Chronic Allograft Rejection

Z. Zhang,¹ Q. Liu,¹ G. Hussey,² J. Dziki,² L. Mathews,¹ H. Dai,¹ G. Dwyer,^1,3 A. Lucas,¹ M. Oberbarnscheidt,¹ S. Badylak,² H. Turnquist.^1,3
Urinary C-X-C Motif Chemokines 13 is a Noninvasive Biomarker of Antibody-Mediated Renal Allograft Rejection

D. Chen, J. Chen.
Urinary C5b-9 is an Independent Predictor of Graft Failure in Renal Transplant Recipients

R. Lammerts, M. Eisenga, M. Alyami, M. Seelen, M. Daha, J. van den Born, S. Bakker, S. Berger, On behalf of the COMBAT Comsortium.
Urinary Cell Cycle Arrest Biomarkers as Early Predictors of Acute Kidney Injury Following Advanced Cardiac Replacement Therapies

S. Joseph, H. Medel-Martinez, T. Bottiglieri, B. Wasek, S. Yeramaneni, J. Felius, C. Bonilla, O. Sido, C. Gottlich, B. Lima, S. Hall.
Urinary Chemokine CXCL-10 in Long Term Renal Transplant Patients Associates with Urinary Tract Infections and Microvascular Damage

G. Irish,^1,2 M. Hockley,^1,2 S. Kireta,^1,2 J. Johnson,^1,2 R. Carroll.^1,2
Urinary CXCL9 Monitoring to Accompany a Safe CNI-to-Belatacept Conversion in Kidney Transplant Patients

P. Malvezzi,¹ C. Fischman,² T. Jouve,¹ B. Janbon,¹ P. Heeger,² L. Rostaing,¹ P. Cravedi.²
Urinary Microbiome Associated with Chronic Allograft Dysfunction in Kidney Transplants

A. Israni,^1,2 A. Muthusamy,² B. Wu,³ B. Guo,³ D. Knights,⁴ G. Al-Ghalith,⁴ J. Wu,¹ W. Oetting,⁵ D. Schladt,² R. Remmel,⁵ P. Jacobson,⁵ For DeKAF Genomics & GEN03 Investigators.¹
Urinary Proteomic Biomarkers for Prediction of Chronic Antibody-Mediated Rejection in Kidney Transplant Recipients

H. Jung,¹ K. Jeong,¹ J-.H. Lim,¹ J. Choi,¹ J-.H. Cho,¹ S-.H. Park,¹ Y-.L. Kim,¹ C-.H. Lee,² M-.C. Baek,² B. Chung,³ S-.H. Lee,⁴ C-.D. Kim.¹
Urinary Proteomics as a Dignostic Mean for Chronic Humoral Rejection after Pediatric Kidney Transplantation

L. Pape, A. Melk, P. Zürbig, N. Kanzelmeyer.
Urinary Sulfate Excretion and Late Graft Failure in Renal Transplant Recipients

M. Said,¹ A. Post,¹ I. Minovic,¹ M. van Londen,¹ H. van Goor,² D. Postmus,³ M. Heiner-Fokkema,⁴ E. van den Berg,¹ A. Pasch,⁵ G. Navis,¹ S. Bakker.¹
Urinary TIMP-2 Predicts the Presence and Duration of Delayed Graft Function in DCD Kidney Transplant Recipients

J. Bank,¹ R. Ruhaak,² D. Soonawala,¹ F. Romijn,² C. van Kooten,¹ C. Cobbaert,² H. de Fijter.¹
Urinary Tract Infections after Renal Transplantation: Is Male Gender a Risk Factor for Resistant Microorganisms?

G. Guneri, A. Velioglu, E. Asicioglu, H. Arikan, S. Tuglular, C. Ozener.
Urinary Tract Infections May Be Associated with De Novo Donor-Specific Anti-Human Leucocyte Antigen Antibodies: Single-Center Study

M. Everly,¹ A. Babu,¹ K. Briley,² P. Bolin,² S. Kendrick,³ H. Jones,³ K. McLawhorn,³ A. Maldonado,⁴ C. Haisch,² D. Leeser,² L. Rebellato.²
Urine AngiotensinII Signature Proteins as Biomarkers of Fibrosis in Kidney Transplant Recipients

Z. Mohammed-Ali,¹ S. Reid,^1,3 T. Tokar,¹ A. Tavares,² P. Yip,¹ H. Cardinal,² Y. Li,¹ S. Kim,^1,3 I. Jurisica,^1,3 R. John,¹ A. Konvalinka.^1,3
Urine Pellet Podocyte mRNAs Correlate Closely with Late Kidney Allograft Loss-of-Function

A. Naik,¹ J. Aqeel,¹ D. Cibrik,² M. Samaniego,¹ M. Chowdhury,¹ S. Wang,¹ F. Afshinnia,¹ R. Wiggins.¹
Urine Podocin mRNA to Nephrin mRNA Ratio as a Marker of "Podocyte Stress" among Kidney Allografts Losing Function

A. Naik,¹ J. Aqeel,¹ D. Cibrik,² M. Samaniego,¹ S. Wang,¹ M. Chowdhury,¹ F. Afshinnia,¹ R. Wiggins.¹
Urological Complications of Prophylactic Ureteral Stent vs. No Stent in Kidney Transplant Recipients at Erie County Medical Center (ECMC)

M. Hamid,¹ J. Kumar,¹ S. Anjum,¹ S. Patel,² G. Gudleski,⁴ S. Mietz,³ M. Ott,³ S. Chang.¹
Use of Cyclin-Dependent Kinase Inhibitors to Reduce Gammaherpesvirus Reactivation

J. Hazleton,¹ L. van Dyk.²
Use of Granulocyte Colony-Stimulating Factor for Leukopenia Post-Renal Transplant

S. Hamel,¹ V. Kuo,² D. Johnson,¹ R. Bloom,³ D. Sawinski,³ J. Trofe-Clark.^1,3
Use of HCV Ab+/NAT- Donors in HCV Naïve Renal Transplant Recipients

A. Dao,¹ M. Cuffy,¹ T. Kaiser,¹ A. Loethen,¹ J. Cafardi,² A. Shields,² M. Cardi,² R. Alloway,¹ A. Govil,¹ K. Sherman,¹ S. Shah,¹ E. Woodle.¹
Use of Hepatitis-C Treatments after Kidney Transplantation: Impact of the Direct-Acting Antiviral Era

K. Lentine, D. Axelrod,² R. Bloom,³ H. Xiao,¹ D. Segev,⁴ T. Alhamad,⁵ H. Randall,¹ R. Ouseph,¹ V. Dharnidharka,⁵ D. Brennan,⁴ N. Lam,⁶ A. Naik,⁷ G. Hess,⁸ B. Kaiske,⁹ M. Schnitzler.¹
Use of Perfusion Machine after Long Cold Ischemia Time: 3 Years Results

A. Matos,¹ L. Requião-Moura,¹ E. Tonato,¹ M. Souza-Durão,^1,2 M. Borrelli,¹ M. Nogueira,¹ P. Rubio,¹ A. Pacheco-Silva.^1,2
Use of Proton-Pump Inhibitors is Associated with Lower Magnesium and Iron Status and Excess Mortality in Renal Transplant Recipients

A. Gomes-Neto,¹ R. Douwes,¹ M. Eisenga,¹ S. Berger,¹ R. Gans,¹ E. Berg,¹ G. Navis,¹ H. Blokzijl,² S. Bakker.¹
Use of Public Health Service Increased Risk Kidneys in Pediatric Renal Transplant Recipients: Recipient Characteristics

M. Meyers,¹ J. Shults,¹ B. Laskin,¹ P. Porrett,² M. Levine,² P. Abt,² S. Amaral,^1,2 D. Goldberg.¹
Use of Right or Left Kidneys in Living-Donor Kidney Transplantation. Comparative Study of 320 Cases

M. Perosa,¹ J. Branez,¹ H. Noujaim,¹ L. Mota,¹ B. Zeballos,¹ M. Castro,¹ G. Marchini,¹ L. Ianhez,¹ L. Alvim,¹ D. Machado,¹ C. Watanabe,¹ A. Saldanha,² H. Abensur,² W. Luconi,¹ T. Genzini-Miranda,³ R. Haddad,⁴ T. Genzini.¹
Use of Surgically Placed Transversus Abdominis Plane (TAP) Block Catheter with Local Anesthetic Infusion in Renal Transplantation

M. Dib,¹ S. Borden,² T. Schell,¹ P. Stahler,¹ T. Al-Qaoud,¹ E. Martinez,¹ E. Grodstein,¹ A. D'Alessandro,¹ J. Odorico,¹ L. Fernandez,¹ J. Mezrich,¹ R. Redfield,¹ D. Foley,¹ D. Al-Adra,¹ D. Kaufman.¹
Using a Data Analytics Platform to Improve Patient Care in Pediatric Lung Transplantation

B. Scully,¹ K. Hosek,² D. Dash,² K. Carberry,^1,2 E. Melicoff,³ M. Gazzaneo,³ G. Mallory,³ J. Heinle.¹
Using Distal Abdominal Aorta as an Outflow Tract for En Bloc Kidney Transplantation from Infant Donors with Extremely Low Body Weight

H. Dai,^1,2 L. Peng,¹ F. Peng,¹ G. Lan,¹ Y. Wang,¹ J. Chen,¹ L. Liu,¹ C. Gao,¹ Y. Guo,¹ C. Fang,¹ M. Nie,¹ W. Long,¹ S. Yu.¹
Using Machine Learning and Simulation to Compare High Risk Kidney Transplant Survival to Waiting for a Non High Risk Organ

E. Mark, D. Goldsman, P. Keskinocak, B. Gurbaxani.
Using the Explore Transplant Ontario Program to Increase Transplant Knowledge and Readiness among Patients on Maintenance Dialysis

D. Belenko,¹ C. Richardson,¹ V. Gupta,¹ T. Ahmed, N. Edwards, M. Novak,² J. Peipert,³ A. Waterman, I. Mucsi.
Using the Remuzzi Score to Guide Single vs. Dual Transplantation Mitigates the Risk of Early Graft Failure

J. Ayorinde, G. Pettigrew.
Using the SRTR Expected Survival Worksheet to Estimate Expected Number of Events

J. Gregg,¹ K. Womer,¹ K. Andreoni.²
Using Visual Icons to Present Program Transplant Rate Information to the Public: Results of a Randomized Trial

C. Schaffhausen,^1,5 S. Chu,⁴ M. Bruin,⁴ J. Hibbard,³ J. Snyder,^2,5 B. Kasiske,^1,5 A. Israni.^1,2,5
Utility of Combining Stereotactic Body Radiation Therapy (SBRT) to Transarterial Chemoembolization as Destination Therapy for Hepatocellular Cancer (HCC) within Milan Criteria

A. Murali, K. Soota, M. Karwal, T. Tanaka, J. Dunkelberg, M. Voigt.
Utility of Preoperative CT to Guide Perioperative Management for Kidney Transplantation

E. Werlin,¹ J. Walker,² J. Freise,¹ P. Stock,¹ J. Hiramoto.²
Utilization of Older Donor after Cardiac Death Allografts in Liver Transplantation: An Opportunity to Increase the Donor Pool

F. Paterno, K. Wima, T. Diwan, M. Cuffy, N. Anwar, E. Woodle, S. Shah.
Utilization of Public Health Service Increased Risk Kidneys in Pediatric Renal Transplant Recipients by Era

M. Meyers,¹ J. Shults,¹ B. Laskin,¹ P. Porrett,² M. Levine,² P. Abt,² S. Amaral,^1,2 D. Goldberg.²